MEM Intrinsic Valuation and Fundamental Analysis - Memphasys Ltd

Watchlist Manager

Watchlist

Price on Oct 14: 0.005 AUD

Market Cap: AU$15.4m

Prices of ASX stocks are not being updated. The latest MEM price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.

M	Memphasys Ltd ASX:MEM	AU
	Astellas Pharma Inc F:YPHA	JP
O	Old National Bancorp F:ON1	US
	Santec Holdings Corp F:8AU	JP
	ALM Equity AB F:I53	SE
	Lifecore Biomedical Inc F:LDE	US
M	Mitsubishi Chemical Holdings Corp F:M3C	JP

Intrinsic Value

MEM doesn't have a meaningful market cap.

Is MEM undervalued or overvalued?

See the intrinsic value estimate for Memphasys Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MEM Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with MEM’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price AU$0.01

Intrinsic Value Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Memphasys Does

Life Sciences Tools & Services Health Care

Memphasys Ltd. is a life sciences company, which engages in the development and commercialization of novel reproduction and fertility solutions for humans and animals. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The firm is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals.

Headquarters: Australia AU
IPO date: May 14, 2007